Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Evolution continues gold production, cost guidance streak

2018-07-19 australianmining.com.au
Gold miner Evolution Mining has achieved its production and cost guidance targets for the seventh consecutive year.
NCMGF NCM NCMGY EVN CAHPF

0
BHP soars as ASX sheds cautious sentiment

2018-07-18 theage.com.au
The Australian sharemarket has rebounded from two days in the red, following a strong session for mining giant BHP Billiton.
BGCHY NCMGF WOPEF NCM BLT MS.PRE MS.PRF MS.PRG MS.PRA OGFGY OISHF BEPTF NWS MS OSH GJV OISHY NWSA BHPBF BGA WPL BCHEY WOPEY BPT TNE NCMGY MS.PRI BHP MS.PRK BBL BHP OGFGF BHPLF ORG

0
BHP soars as ASX sheds cautious sentiment

2018-07-18 smh.com.au
The Australian sharemarket has rebounded from two days in the red, following a strong session for mining giant BHP Billiton.
BGCHY NCMGF WOPEF NCM BLT MS.PRE MS.PRF MS.PRG MS.PRA OGFGY OISHF BEPTF NWS MS OSH GJV OISHY NWSA BHPBF BGA WPL BCHEY WOPEY BPT TNE NCMGY MS.PRI BHP MS.PRK BBL BHP OGFGF BHPLF ORG

4
Metals Investors: Buy GDX, Not GLD

2018-07-17 seekingalpha
In recent months, gold prices have held below $1,300 in situations where bond yields have fallen and stock markets were hit with selling pressure.
NCMGF NCM NCMGY GG

2
Australian shares higher on financial rebound ahead of trade tariff deadline

2018-07-05 theage.com.au
Australian shares advanced for just the third time in ten sessions as modest gains by the finance sector beat out losses made in the material sector following an overnight base metal retreat.
NCMGF NCM RIO BLT RIO EVN BHPBF PRU RSG RTPPF NCMGY RMGGY BHP RIO PMNXF RMGGF RTNTF BBL BHP CAHPF PRU BHPLF

2
Australian shares higher on financial rebound ahead of trade tariff deadline

2018-07-05 smh.com.au
Australian shares advanced for just the third time in ten sessions as modest gains by the finance sector beat out losses made in the material sector following an overnight base metal retreat.
NCMGF NCM RIO BLT RIO EVN BHPBF PRU RSG RTPPF NCMGY RMGGY BHP RIO PMNXF RMGGF RTNTF BBL BHP CAHPF PRU BHPLF

0
Newcrest’s gold hunt in northern Australia continues

2018-07-04 australianmining.com.au
Newcrest Mining has signed a farm-in agreement with Prodigy Gold over the Euro gold project in the Tanami region of the Northern Territory.
NCMGF ENR NCM NCMGY ABMMF ABU

1
Newcrest receives $US155m Cadia earthquake insurance settlement

2018-06-21 australianmining.com.au
Newcrest Mining has settled its insurance claim regarding damage sustained at its Cadia gold mine operation in New South Wales following an earthquake in April 2017. The settlement figure of $US155 million ($210.5 million) will be included in the company’s statutory profit for the 2018 financial year (FY2018).
NCMGF NCM NCMGY

3
Emmerson Resources reveals early stage copper-gold discovery in New South Wales

2018-06-14 proactiveinvestors.com.au
Emmerson Resources Limited (ASX:ERM) has received encouraging results from the first pass fieldwork at the Whatling Hill copper-gold prospect within its Fifield project in New South Wales.
NCMGF NCM NCMGY EVN AMI RRL 3993 CAHPF ERM RGRNF EMMRF

1
CME, Paladin announce new CEOs

2018-06-12 businessnews.com.au
The Chamber of Minerals and Energy of WA today confirmed the appointment of Paul Everingham as its new chief executive while uranium miner Paladin Energy has recruited a former Newcrest Mining executive to lead the company.
PDN PALAY NCMGF PALAF NCM NCMGY PDN

1
Kore Potash appoints Stuart Bradley Sampson as new chief executive officer

2018-05-30 proactiveinvestors.com.au
Kore Potash PLC (LON:KP2) (ASX:KP2) has appointed Stuart Bradley Sampson as chief executive officer and director, effective from 4 June 2018.
NCMGF NCM NCMGY TGS TRSDF

34
Australian gold output strong despite wet weather

2018-05-27 australianmining.com.au
Australian gold production in Western Australia and Queensland has been interrupted by wet weather in the early months of 2018.
NCMGF NCM ABX NCMGY NEM IGO IIDDY ABX

1
Encounter Resources raises $2.75 million to advance its projects in Western Australia

2018-05-25 proactiveinvestors.com.au
Encounter Resources Ltd (ASX:ENR) has received firm placement commitments from professional and sophisticated investors to raise about $2.75 million at 6 cents per share.
NCMGF ENR NCM NCMGY

152
Top 20 Gold Stocks to Buy Despite Irrational Markets

2018-05-21 investorplace
Although the markets have their own logic, highly capitalized gold-mining companies seemingly should belong on any “stocks to buy” list. Thanks to rising geopolitical tensions and soaring trading sentiment, many folks seek safe-haven assets. While gold stocks seemingly offer a viable solution, their overall performance has been unusually disappointing.
HMY NCMGF NCM GFI.WI FNV NEM EVN YRI NGDAF BVN NGD RRS AGI SLW KGC BTG AUY AMGGF AEM CAHPF GFIOF IAG GG HGMCF EGO ABX WPM FNV.WT.A NGD ABX RGORF K GOLD AGI SLW GOLD RGLD NCMGY ELD GFI FNV RGL

3
Almadex Minerals Ltd. and Azucar Minerals Ltd. Announce Closing of Arrangement

2018-05-18 globenewswire
VANCOUVER, British Columbia, May 18, 2018 (GLOBE NEWSWIRE) -- Almadex Minerals Limited (“Old Almadex”) is pleased to announce that it has closed the previously announced statutory plan of arrangement (the “Plan of Arrangement”) under Section 288 of the Business Corporations Act (British Columbia) to spin-out Old Almadex’s early stage exploration projects, royalty interests, and certain other assets into Almadex Minerals Ltd.
AMZ NCMGF NCM NCMGY AXDDF

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...